Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· KEN WASSERMANAudio: American English

Rewriting the body's operating system for longevity

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: American English

Multiple interventions for increasing longevity and addressing the core mechanisms of aging are discussed. Systemic effects of GLP-1 receptor agonists, therapeutic plasma exchange, senolytic approaches, which selectively eliminate senescent cells or disrupt their harmful secretions, and cellular reprogramming, which uses genetic manipulation to reverse cells to a more youthful, pluripotent state can now be combined, and clinical trials based on these combinations are highly likely to be successful. Furthermore, the authors introduce a burgeoning area of research—the modulation of mitotic competence—suggesting it as a promising alternative anti-aging strategy. This novel approach focuses on improving the fidelity of cell division to prevent age-associated aneuploidy and subsequent cellular senescence, offering a way to circumvent limitations found in the more established senolytic and reprogramming methods.

KEN WASSERMAN · 16 min · Source published: 2025-11-24

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…